Chemohyperthermia with Mitomycin C (MMC) and COMBAT System in High Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC): A New Alternative? Abstract PDF

Hyperthermic Intravesical Chemotherapy for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Patients. Abstract PDF

Chemohyperthermia with Mitomycin C and COMBAT System in High Risk Non-Muscle Invasive Bladder Cancer Patients: Initial Experience in a Single Centre. Abstract PDF

Heat Targeted Drug Delivery (COMBAT) in Superficial TCC: First Midterm Results in a Cohort of High-Risk Patients Scheduled for Cystectomy. Abstract PDF

The Role of Conductive Hyperthermia with Mitomycin C in High Risk Non Muscle Invasive Bladder Cancer that has Failed BCG Therapy. Abstract PDF

Hyperthermic Intravesical Chemotherapy for BCG-Unresponsive or BCG Ineligible Non-Muscle Invasive Bladder Cancer Patients. Abstract PDF

Intravesical Thermo-Chemotherapy using the Combined Antineoplastic Thermotherapy Bladder Recirculation System for Patients with High Risk, Non-Muscle Invasive Bladder Cancer – Early Results. Abstract PDF

One Year Follow up Results After Sequential Intravesical Bacillus Calmette-Guérin and Device Assisted Chemo-Hyperthermia (Mitomycin C delivered by The COMBAT BRS System) for High Risk Non-Muscle Invasive Bladder Cancer Patients… A Bacillus Calmette-Guérin Sparing Strategy. Abstract PDF

Two-year Follow-up Results After Sequential Intravesical Bacillus Calmette-Guérin (BCG) and Device-Assisted Chemo-Hyperthermia (Combat BRS) for High-Risk (HR) Non-Muscle Invasive Bladder Cancer (NMIBC) Patients…a BCG-Sparing Strategy. Abstract PDF

Safety and Tolerability Analysis of Hyperthermic Intravesical Mitomycin to Mitomycin alone in HIVEC I and HIVEC II: An Interim Analysis of 307 Patients. Abstract PDF

Recirculant Hyperthermic IntraVEsical Chemotherapy (HIVEC) in Intermediate – High Risk Non-Muscle Invasive Bladder Cancer. Abstract PDF

Heat Targeted Drug Delivery using the COMBAT BRS Device for Treating Bladder Cancer. Abstract PDF

Thermal Dosimetry for Bladder Hyperthermia Treatment; An Overview. Abstract PDF

Hyperthermia as Adjunct to Intravesical Chemotherapy for Bladder Cancer. Abstract PDF

Enchancement by Hyperthermia of the in Vitro Cytotoxicity of Mitomycin C toward Hypoxic Tumor Cells. Abstract PDF

Quality of Life (QoL), Non Muscle Invasive Bladder Cancer (NMIBC) and Endovesical Treatments: Installation matters Abstract PDF